Synthesis, topoisomerase I inhibition and antitumor cytotoxicity of 2,2′:6′,2″-, 2,2′:6′,3″- and 2,2′:6′,4″-Terpyridine derivatives
作者:Long-Xuan Zhao、Tae Sung Kim、Soo-Hyun Ahn、Tae-Hyung Kim、Eun-kyung Kim、Won-Jea Cho、Heesung Choi、Chong-Soon Lee、Jung-Ae Kim、Tae Cheon Jeong、Ching-jer Chang、Eung-Seok Lee
DOI:10.1016/s0960-894x(01)00531-5
日期:2001.10
new anticancer agents, 2,2':6',2"-, 2,2':6',3"- and 2,2':6',4"-terpyridine derivatives were designed and evaluated for their topoisomerase I inhibitory activity and antitumor cytotoxicity. Structure-activity relationship studies indicated that 2,2':6',2"-terpyridine derivatives were highly cytotoxic toward several human tumor cell lines, whereas 2,2':6',3"- and 2,2':6',4"-terpyridine derivatives were
为了开发新的抗癌药,设计并评估了2,2':6',2“-,2,2':6',3”-和2,2':6',4“-吡啶衍生物结构-活性关系研究表明,2,2':6',2“-叔吡啶衍生物对几种人类肿瘤细胞系具有高度的细胞毒性,而2,2':6',3”对它们的拓扑异构酶I抑制活性和抗肿瘤细胞毒性。 -和2,2':6',4“-吡啶吡啶衍生物是有效的拓扑异构酶I抑制剂。